Skip to main content
SpringerLink
Log in

Eliciting Hyperacute Rejection as a Tumor Killing Strategy

Herpes Amplicon Vector Transfer of the α(1,3)Galactosyltransferase Gene

  • Chapter
  • First Online:
Cancer Gene Therapy

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 465))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Andersen, J.K., Garber, D.A., Meaney, C.A., and Breakefield, X.O. (1992). “Gene transfer into mammalian central nervous system using herpes virus vectors: extended expression of bacterial lacZ in neurons using the neuron-specific enolase promoter”. Hum. Gene. Ther., 3(5), 487–499.

    Article  CAS  PubMed  Google Scholar 

  • Boviatsis, E.J., Scharf, J.M., Chase, M., Harrington, K., Kowall, N.W., Breakefield, X.O., and Chiocca, E.A. (1994). “Antitumor activity and reporter gene transfer into rat brain neoplasms inoculated with herpes simplex virus vectors defective in thymidine kinase or ribonucleotide reductase”. Gene. Ther., 1(5), 323–331.

    CAS  PubMed  Google Scholar 

  • Chambers, R., Gillespie, G.Y., Soroceanu, L., Andreansky, S., Chatterjee, S., Chou, J., Roizman, B., and Whitley, R.J. (1995). “Comparison of genetically engineered herpes simplex viruses for the treatment of brain tumors in a scid mouse model of human malignant glioma”. Proc. Natl. Acad. Sci. U.S.A., 92(5), 1411–1415.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Chen, S., Li Chen, X.H., Wang, Y., Kosai, K., Finegold, M.J., Rich, S.S., and Woo, S.L. (1995). “Combination gene therapy for liver metastasis of colon carcinoma in vivo”. Proc. Natl. Acad. Sci., 92, 2577–2581.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Chiocca, E.A., Choi, B.B., Cai, W.Z., DeLuca, N.A., Schaffer, P.A., DiFiglia, M., Breakefield, X.O., and Martuza, R.L. (1990). “Transfer and expression of the lacZ gene in rat brain neurons by herpes simplex virus mutants”. New Biol., 2, 739–746.

    CAS  PubMed  Google Scholar 

  • Collins, M.K., Takeuchi, Y., Cosset, F.L., Tailor, C., and Weiss, R.A. (1994). “Development of recombinant retroviruses suitable for in vivo gene delivery”. Cold Spring Harbor Meeting: Gene Therapy, Sept. 1994, 97.

    Google Scholar 

  • Dranoff, G., Jaffee, E., Lazenby, A., Golumbek, P., Levitsky, H., Brose, K., Jackson, V., Hamada, H., Pardoll, D., and Mulligan, R. (1993). “Vaccination with irradiated tumor cells engineered to secrete murine GM-CSF stimulates potent, specific and long lasting anti-tumor immunity”. Proc. Natl. Acad. Sci. (USA), 90, 3539–3543.

    Article  CAS  Google Scholar 

  • During, M.J., Naegele, J.R., O’Malley, K.L., and Geller, A.I. (1994). “Long-term behavioral recovery in Parkinsonian rats by an HSV vector expressing tyrosine hydroxylase”. Science, 266, 1399–1403.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Fearon, E.R., Pardoll, D.M., Itaya, T., Golumbek, P., Levitsky, H.I., Simons, J.W., Karasuyama, H., Vogelstein, B., and Frost, P. (1990). “Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response”. Cell, 60, 397–403.

    Article  CAS  PubMed  Google Scholar 

  • Galili, U., (1993). “Evolution and pathophysiology of the human natural anti-alpha-galactosyl IgG (anti-Gal) antibody”. Springer Semin Immunopathol, 15, 155.

    Article  CAS  PubMed  Google Scholar 

  • Galili, U., and Latemple, D.C. (1997). “Natural anti-gal antibody as a universal augmentor of autologous tumor vaccine immunogenicity”. Immunol Today, 18, 281–285.

    Article  CAS  PubMed  Google Scholar 

  • Galili, U., Shohet, S.B., Kobrin, E., Stults, C.L., and Macher, B.A. (1988). “Man, apes, and Old World monkeys differ from other mammals in the expression of alpha-galactosyl epitopes on nucleated cells”. J. Biol. Chem., 263(33), 17755–17762.

    Article  CAS  PubMed  Google Scholar 

  • Galili, U, Tibell, A., Samuelsson, B., Rydberg, L., and Groth, C.G. (1995). “Increased anti-Gal activity in diabetic patients transplanted with fetal porcine islet cell clusters”. Transplantation, 59(11), 1549–1556.

    Article  CAS  PubMed  Google Scholar 

  • Geller, A.I., and Breakefield, X.O. (1988). “A defective HSV-1 vector expresses Escherichia coli β-galactosidase in cultured peripheral neurons”. Science, 241, 1667–1669.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Geller, A.I., and Freese, A. (1990). “Infection of cultured central nervous system neurons with a defective herpes simplex virus 1 vector results in stable expression of Escherichia coli beta-galactosidase”. Proc. Natl. Acad. Sci. U.S.A., 87, 1149–1153.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Glorioso, J.C., DeLuca, N.A., and Fink, D.J. (1995). “Development and application of herpes simplex virus vectors for human gene therapy”. Annu. Rev. Microbiol., 49, 675–710.

    Article  CAS  PubMed  Google Scholar 

  • Goldie, J.H., and Coldman, A.J. (1979). “A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate”. Cancer Treat. Rep., 63(11–12), 1727–1733.

    CAS  PubMed  Google Scholar 

  • Golumbek, P.T., Lazenby, A.J., Levitsky, H.I., Jaffee, L.M., Karasuyama, H., Baker, M., and Pardoll, D.M. (1991). “Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4”. Science, 254, 713–716.

    Article  CAS  PubMed  Google Scholar 

  • Ho, D., Mocarski, E., and Sapoloski, R. (1993). “Altering central nervous system physiology with a defective herpes simplex virus vector expressing the glucose transporter gene”. Proc. Natl. Acad. Sci. U.S.A., 90, 3655–3659.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kwong, A.D., and Frenkel, N. (1984). “Herpes simplex virus amplicon: Effect of size on replication of constructed defective genomes containing eukaryotic DNA sequences”. J. Virol., 51, 595–603.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kwong, A.D., and Frenkel, N. (1985). “The Herpes simplex virus amplicon. Efficient expression of a chimeric chicken ovalbumin gene amplified within defective virus genomes”. Virology, 142, 421–425.

    Article  CAS  PubMed  Google Scholar 

  • Larsen, R.D., Rajan, V.P., Ruff, M.M., Kukowska-Latallo, J., Cummings, R.D., and Lowe, J.B. (1989). “Isolation of a cDNA encoding a murine UDPgalactose:beta-D-galactosyl-1,4-N-acetyl-D-glucosaminide alpha-1,3-galactosyltransferase: expression cloning by gene transfer”. Proc. Natl. Acad. Sci. U.S.A., 86(21), 8227–8231.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Larsen, R.D., Rivera-Marrero, C.A., Ernst, L.K., Cummings, R.D., and Lowe, J.B. (1990). “Frameshift and nonsense mutations in a human genomic sequence homologous to a murine UDP-Gal:beta-D-Gal(l,4)-D-GlcNAc alpha(l,3)-galactosyltransferase cDNA”. J. Biol. Chem., 265(12), 7055–7061.

    Article  CAS  PubMed  Google Scholar 

  • Link, C.J., Levy, J.P., Seregina, T., Atchinson, R., and Moorman, D. (1997). “Protection of complement mediated lysis of murine vector producer cells by sCR1 and low molecular weight heparins”. Cancer Gene Therapy, H. Mazarakis and S.J. Swart, eds., 1BC Library Series, London, United Kingdom, 135–152.

    Google Scholar 

  • Link, C.J., Jr., Moorman, D., Seregina, T, Levy, J.P., and Schabold, K.J. (1996). “A phase I trial of in vivo gene therapy with the herpes simplex thymidine kinase/ganciclovir system for the treatment of refractory or recurrent ovarian cancer”. Hum. Gene. Ther., 7(9), 1161–1179.

    Article  PubMed  Google Scholar 

  • Link, C.J., Seregina, T.S., Atchison, R., Hall, A., Muldoon, R., and Levy, J.P. (1998). “Eliciting hyperacute xenograft response to treat uman cancer: α(1,3)galactosyltransferase gene therapy”. Anticancer Res., 18, 2301–2308.

    CAS  PubMed  Google Scholar 

  • Martuza, R.L., Malick, A., Markert, J.M., Ruffner, K.L., and Coen, D.M. (1991). “Experimental therapy of human glioma by means of a genetically engineered virus mutant”. Science, 252, 854–856.

    Article  CAS  PubMed  Google Scholar 

  • Miller, A.D., and Buttimore, C. (1986). “Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production”. Molec. Cell Biol., 6, 2895–2902.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Miller, D.G., Adam, M.A., and Miller, A.D. (1990). “Gene transfer by retrovirus vectors occurs in cells that are actively replicating at the time of infection”. Mol. Cell Biol., 10, 4139–4242.

    Google Scholar 

  • Mineta, T., Markert, J.M., Takamiya, Y., Coen, D.M., Rabkin, S.D., and Martuza, R.L. (1994). “CNS tumor therapy by attenuated herpes simplex viruses”. Gene. Ther., 1(1).

    Google Scholar 

  • Nabel, G.J., Nabel, E., Yang, Z., Fox, B.A., Plautz, G.E., Gao, X., Huang, L., Shu, S., Gordon, D., and Chang, A.E. (1993). “Direct gene transfer with DNA-liposome complexes in melanoma: Expression, biologic activity, and lack of toxicity in humans”. Proc. Natl. Acad. Sci. (USA), 90, 11307–11311.

    Article  CAS  Google Scholar 

  • Palella, T.D., Hidaka, Y., Silverman, L.J., Levine, M., Glorioso, J., and Kelley, W.N. (1989). “Expression of human HPRT mRNA in brains of mice infected with a recombinant herpes simplex type 1 vector”. Gene., 80, 137–144.

    Article  CAS  PubMed  Google Scholar 

  • Parker, S.L., Tong, T., Bolden, S., and Wingo, P.A. (1997). “Cancer statistics, 1997”. CA, Cancer J. for Clinicians, 47, 5–27.

    Article  CAS  Google Scholar 

  • Platt, J.L., Vercellotti, G.M., Dalmasso, A.P., Matas, A.J., Bolman, R.M., Najarian, J.S., and Bach, F.H. (1990). “Transplantation of discordant xenografts: a review of progress”. Immunol. Today, 17, 450–457.

    Article  Google Scholar 

  • Pruitt, S.K., Kirk, A.D., Bollinger, R.R., Marsh, J., Henry, C., Collins, B.H., Levin, J.L., Mault, J.R., Heinle, J.S., Ibrahim, S., Rudolph, A.R., Baldwin, I., William, M., and Sanfilippo, F. (1994). “The effect of soluble complement receptor type 1 on hyperacute rejection of porcine xenografts”. Transplantation, 57, 363–370.

    Article  CAS  PubMed  Google Scholar 

  • Ram, Z., Culver, K.W., Oshiro, E.M., Viola, J.J., DeVroom, H.L., Otto, E., Long, Z., Chiang, Y., McGarrity, G.J., Muul, L.M., Katz, D., Blaese, R.M., and Oldfield, E.H. (1997). “Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells [see comments]”. Nat. Med., 3(12), 1354–1361.

    Article  CAS  PubMed  Google Scholar 

  • Reeves, M.E., Royal, R.E., Lam, J.S., Rosenberg, S.A., and Hwu, P. (1996). “Retroviral transduction of human dendritic cells with a tumor-associated antigen gene”. Cancer Res., 56(24), 5672–5677.

    CAS  PubMed  Google Scholar 

  • Reisman, D., Yates, J., and Sugden, B. (1985). “A putative origin of replication of plasmids derived from Epstein-Barr virus is composed of two cis-acting components”. Mol. Cell. Biol., 5, 1822–1832.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Roth, J.A., Cristiano, R.J., Roth, J.A., and Cristiano, R.J. (1997). “Gene therapy for cancer: what have we done and where are we going?” J. Natl. Cancer Inst., 89(1), 21–39.

    Article  CAS  PubMed  Google Scholar 

  • Rother, R.P., Fodor, W.L., Springhorn, J.P., Birks, C.W., Setter, E., Sandrin, M.S., Squinto, S.P., and Rollins, S.A. (1995a). “A novel mechanism of retrovirus inactivation in human serum mediated by anti-alpha-galactosyl natural antibody”. J. Exp. Med., 182(5), 1345–1355.

    Article  CAS  PubMed  Google Scholar 

  • Rother, R.P., Squinto, S.P., Mason, J.M., and Rollins, S.A. (1995b). “Protection of retroviral vector particles in human blood through complement inhibition”. Hum. Gene. Ther., 6(4), 429–435.

    Article  CAS  PubMed  Google Scholar 

  • Sandrin, M.S., Vaughan, H.A., Dabkowski, PL., and McKenzie, I.F. (1993). “Anti-pig IgM antibodies in human serum react predominantly with Gal(alpha l-3)Gal epitopes”. Proc. Natl. Acad. Sci. U.S.A., 90(23), 11391–11395.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Schwartz, R.S., Silberstein, L.E., and Berkman, E.M. (1995). “Autoimmune hemolytic anemia”. Hematology Basic Principles and Practice, R. Hoffman, E.J. Benz, S.J. Shattil, B. Furie, H.J. Cohen, and L.E. Silberstein, eds., Churchill Livingstone, New York, 723–724.

    Google Scholar 

  • Seregina, T., Levy, J., and Link, C. “Development of ganciclovir resistance in cells transduced with the HStk gene”. Fourth International Conference on the Gene Therapy of Cancer, San Diego, CA, A332.

    Google Scholar 

  • Short, M.P., Choi, B.C., Lee, J.K., Malick, A., Breakefield, X.O., and Martuza, R.L. (1990). “Gene delivery to glioma cells in rat brain by grafting of a retrovirus packaging cell line”. J. Neurosci. Res., 27, 427–439.

    Article  CAS  PubMed  Google Scholar 

  • Spaete, R.R., and Frenkel, N. (1982). “The herpes simplex virus amplicon: A new eukaryotic defective-virus cloning-amplifying vector”. Cell, 30, 295–304.

    Article  CAS  PubMed  Google Scholar 

  • Sugden, B., Marsh, K., and Yates, J. (1985). “A vector that replicates as a plasmid and can be efficiently selected in B-lymphoblasts transformed by Epstein-Barr virus”. Molec Cell Biol, 5(2), 410–413.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Takamiya, Y., Short, M.P., Ezzeddine, Z.D., Moolten, F.L., Breakefield, X.O., and Martuza, R.L. (1992). “Gene therapy of malignant brain tumors: a rat glioma line bearing the herpes simplex virus type 1-thymidine kinase gene and wild type retrovirus kills other tumor cells”. J. Neurosci Res., 33(3), 493–503.

    Article  CAS  PubMed  Google Scholar 

  • Vaughan, H.A., McKenzie, I.F., and Sandrin, M.S. (1995). “Biochemical studies of pig xenoantigens detected by naturally occurring human antibodies and the galactose alpha( l-3)galactose reactive lectin”. Transplantation, 59(1), 102–109.

    Article  CAS  PubMed  Google Scholar 

  • Wang, S., and Vos, J. (1996). “A hybrid infectious vector based on Epstein-Barr virus and Herpes simplex virus type I for gene transfer into Human Gene”. J Virol, 70, 8422–8430.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wang, S., Young, W.-B., Jacobson, C., and Link, C.J. (1997). “A novel Herpesvirus amplicon system for in vivo gene therapy”. Gene. Ther., 4, 1132–1141.

    Article  CAS  PubMed  Google Scholar 

  • Welsh, R.M., Cooper, N.R., Jensen, F.C., and Oldstone, M.B. (1975). “Human serum lyses RNA tumor viruses”. Nature, 257, 612–614.

    Article  CAS  PubMed  Google Scholar 

  • Witzig, T.E., Ingle, J.N., Schaid, D.J., Wold, L.E., Barlow, J.F., Gonchoroff, N.J., Gerstner, J.B., Krook, J.E., Grant, C.S., and Katzmann, J.A. (1993). “DNA ploidy and percent S-phase as prognostic factors in node-positive breast cancer: results from patients enrolled in two prospective randomized trials”. J. Clin. Oncol., 11(2), 351–359.

    Article  CAS  PubMed  Google Scholar 

  • Wood, C., Kabat, E.A., Murphy, L.A., and Goldstein, I.J. (1979). “Immunochemical studies on the cpmbining site of two isolectins A4 and B4 isolated from Bandeirea simpliciflia”. Arch. Biochem. Biophys., 198, 1–11.

    Article  CAS  PubMed  Google Scholar 

  • Yates, J.L., Warren, N., and Sugden, B. (1985). “Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells”. Nature, 313, 812–815.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Human Gene Therapy Research Institute, 1415 Woodland Avenue, Suite 218, Des Moines, Iowa, 50309, USA

    Charles J. Link, Daniel J. Hellrung, Tatiana Seregina & Suming Wang

Authors
  1. Charles J. Link
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Daniel J. Hellrung
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tatiana Seregina
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Suming Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Imperial College School of Medicine, Hammersmith Hospital, London, UK

    Nagy A. Habib

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Kluwer Academic Publishers

About this chapter

Cite this chapter

Link, C.J., Hellrung, D.J., Seregina, T., Wang, S. (2002). Eliciting Hyperacute Rejection as a Tumor Killing Strategy. In: Habib, N.A. (eds) Cancer Gene Therapy. Advances in Experimental Medicine and Biology, vol 465. Springer, New York, NY. https://doi.org/10.1007/0-306-46817-4_20

Download citation

  • DOI: https://doi.org/10.1007/0-306-46817-4_20

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-306-46191-0

  • Online ISBN: 978-0-306-46817-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation